Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

IceCure Medical (ICCM) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $17.3 million as the latest value for Q4 2022.

  • On a quarterly basis, Long-Term Deferred Tax rose 21.84% to $17.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was $17.3 million, a 21.84% increase, with the full-year FY2022 number at $17.3 million, up 21.84% from a year prior.
  • Long-Term Deferred Tax was $17.3 million for Q4 2022 at IceCure Medical, up from $14.2 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $17.3 million in Q4 2022 to a low of $14.2 million in Q4 2021.